<DOC>
	<DOC>NCT03047538</DOC>
	<brief_summary>The aim of this study is to compare the effect of fixed and free combination of atorvastatin/perindopril/amlodipine on blood pressure and lipid levels.</brief_summary>
	<brief_title>Fixed Combination for Lipid and Blood Pressure Control</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Lipid Metabolism Disorders</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Perindopril</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Patients with uncontrolled arterial hypertension (the average 24h blood pressure in the range 130/80 180/110 mmHg and / or daytime average blood pressure in the range 135/85180/110 mmHg) and one of the following: 1. a very high cardiovascular risk and LDLcholesterol&gt; 1.8 mmol / l 2. a high cardiovascular risk and LDLcholesterol&gt; 2.5 mmol / l 3. Patient with a high or very high cardiovascular risk treated by lipidlowering therapy with statin 1. hypersensitivity to perindopril or to other ACE inhibitors, amlodipine, atorvastatin, dihydropyridines or to or statins 2. angioneurotic edema in medical history (hereditary / idiopathic or associated with prior treatment with ACE inhibitors) 3. severe hypotension, shock, including cardiogenic shock 4. hemodynamically unstable heart failure 5. Active liver disease or unexplained persistent elevations of serum transaminases more than three times normal 6. Women of childbearing age without reliable contraception 7. pregnancy 8. breastfeeding 9. Patients with contraindications listed in the currently valid SP</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Arterial hypertension</keyword>
	<keyword>Dyslipidemia</keyword>
	<keyword>Blood pressure control</keyword>
	<keyword>Fixed combination</keyword>
</DOC>